Actualizado 31/08/2011 10:02
- Comunicado -

New Data Demonstrating Long-term Benefits of FIRMAGON® (degarelix) for Advanced Hormone-dependant Prostate Cancer Publis

SAINT--PREX, Switzerland, August 31, 2011 /PRNewswire/ --

CONTACT: Media enquiries: Orla Barnewell, Tonic Life Communications, Tel:+44 207 798 9915, orla.barnewell@toniclc.com; Helen Swift, Tonic LifeCommunications, Tel: +44 207 798 9924, helen.swift@toniclc.com; PatrickGorman, Ferring Pharmaceuticals, Tel: +41 (0) 58 301 00 53patrick.gorman@ferring.com

Contenido patrocinado